Veri Medtech Holdings Statistics
Veri Medtech Holdings (VRHI) Stock Statistics & Valuation Metrics
Total Valuation
Veri Medtech Holdings has a market cap or net worth of $35.28M. The enterprise value is $35.97T.
- Market Cap
- $35.28M
- Enterprise Value
- $35.97T
Share Statistics
Veri Medtech Holdings has 8,000,004 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,000,004
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Veri Medtech Holdings’s return on equity (ROE) is 0.99 and return on invested capital (ROIC) is 123.26%.
- Return on Equity (ROE)
- 0.99
- Return on Assets (ROA)
- -12.63
- Return on Invested Capital (ROIC)
- 123.26%
- Return on Capital Employed (ROCE)
- 0.96
- Revenue Per Employee
- 433.93K
- Profits Per Employee
- -93.42K
- Employee Count
- 25
- Asset Turnover
- 58.68
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Veri Medtech Holdings is -18.25. Veri Medtech Holdings’s PEG ratio is 0.33.
- PE Ratio
- -18.25
- PS Ratio
- 4.24
- PB Ratio
- -11.18
- Price to FCF
- 1278.72
- Price to Operating Cash Flow
- 1278.77
- PEG Ratio
- 0.33
Income Statement
In the last 12 months, Veri Medtech Holdings had revenue of 10.85M and earned -2.34M in profits. Earnings per share was -0.30.
- Revenue
- 10.85M
- Gross Profit
- 8.17M
- Operating Income
- -2.27M
- Pretax Income
- -2.34M
- Net Income
- -2.34M
- EBITDA
- -2.15M
- Earnings Per Share (EPS)
- -0.30
Cash Flow
In the last 12 months, operating cash flow was 27.59K and capital expenditures 0, giving a free cash flow of 27.59K billion.
- Operating Cash Flow
- 27.59K
- Free Cash Flow
- 27.59K
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Veri Medtech Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.08%
- Earnings Yield
- -5.48%
Stock Price Statistics
- Beta
- 0.16
- 52-Week Price Change
- 3.76%
- 50-Day Moving Average
- 4.70
- 200-Day Moving Average
- 3.96
- Relative Strength Index (RSI)
- 27.73
- Average Volume (3m)
- 258
Financial Position
Veri Medtech Holdings as a current ratio of 0.05, with Debt / Equity ratio of -22.12%
- Current Ratio
- 0.05
- Quick Ratio
- 0.05
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- -0.22
- Interest Coverage Ratio
- -33.28
Taxes
In the past 12 months, Veri Medtech Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Veri Medtech Holdings EV to EBITDA ratio is -18.99, with an EV/FCF ratio of 1292.60.
- EV to Sales
- 4.29
- EV to EBITDA
- -18.99
- EV to Free Cash Flow
- 1292.60
- EV to Operating Cash Flow
- 1292.65
Balance Sheet
Veri Medtech Holdings has $19.51K in cash and marketable securities with $402.30K in debt, giving a net cash position of -$382.80K billion.
- Cash & Marketable Securities
- $19.51K
- Total Debt
- $402.30K
- Net Cash
- -$382.80K
- Net Cash Per Share
- -$0.05
- Tangible Book Value Per Share
- -$0.39
Margins
Gross margin is 73.74%, with operating margin of -22.77%, and net profit margin of -23.25%.
- Gross Margin
- 73.74%
- Operating Margin
- -22.77%
- Pretax Margin
- -23.25%
- Net Profit Margin
- -23.25%
- EBITDA Margin
- -22.57%
- EBIT Margin
- -22.77%
Analyst Forecast
The average price target for Veri Medtech Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -5.59%
- EPS Growth Forecast
- -70.88%

